L1CAM and Parkinson disease: Future studies should therefore combine L1CAM with complementary markers, such as light neurofilament, synaptophysin, or other neuron‐specific proteins or RNAs, to more accurately determine the cellular origin of EVs in Parkinson's disease and related conditions.